ArticleAnnals of translational medicine2022

Comparison of the efficacy and safety of caplacizumab versus placebo in thrombotic thrombocytopenic purpura: a meta-analysis and systematic review based on randomized controlled trials.

Bin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.